Chemicals & Advanced Materials Global On demand · 24-48h

Global Medicine Blister Market Strategic Research Report

Global Medicine Blister Market Strategic Research Report
$3,500 USD
Market Research Reports
Strategic Research Report
Global Medicine Blister Market
$6.94B2025
5.9%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: PVC, PVDC, Aluminum Foil, Aclar, Others

By Application: Tablets Drug, Capsule Drug, Other

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Amcor, Constantia Flexibles, Klöckner Pentaplast, Liveo Research GmbH, WestRock, Tekni-plex, Honeywell, CPH GROUP, HySum, Bilcare, Sumitomo Bakelite, Jiangsu zhongjin matai, SÜDPACK Medica, Guangdong DFP New Material, Syensqo, Uniworth, Goldstone Packaging

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 131 pages
Market size 2025
$6.94B
Billion USD
Forecast CAGR
5.9%
2025-2032
Forecast 2032
$10.4B
Projected
Gebieden
5
Asia Pacific · Latin America · MEA · Europe · North America

Overzicht

Scope of the Report

The global Medicine Blister market size is predicted to grow from US$ 6,943 million in 2025 to US$ 10,310 million in 2032; it is expected to grow at a CAGR of 5.9% from 2026 to 2032.

Blister film for drug packaging is a packaging method that seals the product between a blister formed by a transparent plastic sheet and a base plate (usually made of aluminum foil or plastic film, etc.). The blister packaging of drugs is formed by vacuum blistering (blowing) or compression molding, and after the blister is filled with drugs, a covering material such as aluminum foil is used to heat-seal it with the blister base material under certain temperature and time conditions by pressure.

The global medicine blister packaging market is primarily driven by the increasing demand for unit-dose packaging in pharmaceuticals, which enhances drug safety, extends shelf life, and improves patient compliance. Blister packs offer excellent barrier protection against moisture, light, and contamination, making them ideal for solid oral dosage forms such as tablets and capsules. In addition, the growth of the elderly population, rising incidences of chronic diseases, and regulatory emphasis on traceability and tamper-evidence further accelerate the adoption of blister packaging in both prescription and over-the-counter (OTC) drug segments.Despite strong demand, the medicine blister packaging market faces several challenges. One of the primary obstacles is the high cost of aluminum and high-barrier polymer materials used in blister packs, which can increase production expenses—especially for generic drug manufacturers. Furthermore, sustainability concerns are mounting, as most traditional blister packs are difficult to recycle due to their multi-material composite structure (e.g., aluminum-PVC). Regulatory pressure and consumer expectations are pushing manufacturers toward more eco-friendly solutions, which often require significant investments in new materials and equipment.

This report presents a comprehensive overview of the global Medicine Blister market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • PVC
  • PVDC
  • Aluminum Foil
  • Aclar
  • Others

Segment by Application

  • Tablets Drug
  • Capsule Drug
  • Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Medicine Blister market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Tablets Drug, Capsule Drug, Other evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Medicine Blister Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.9%
Regional growth momentum
Market share by segment
Key metrics
Base value
$6.94B
2025
Forecast
$10.4B
2032
CAGR
5.9%
2025–2032
Gebieden
5
global
Key companies
AmcorConstantia FlexiblesKlöckner PentaplastLiveo Research GmbHWestRockTekni-plexHoneywellCPH GROUP
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
PVCPVDCAluminum FoilAclarOthers
By Application
Tablets DrugCapsule DrugOther

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 PVC
  • 3.1.3 PVDC
  • 3.1.4 Aluminum Foil
  • 3.1.5 Aclar
  • 3.1.6 Others
  • 3.1.7 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Tablets Drug
  • 4.1.3 Capsule Drug
  • 4.1.4 Other
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Amcor
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Constantia Flexibles
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Klöckner Pentaplast
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Liveo Research GmbH
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 WestRock
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Tekni-plex
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Honeywell
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 CPH GROUP
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 HySum
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Bilcare
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Sumitomo Bakelite
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Jiangsu zhongjin matai
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 SÜDPACK Medica
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Guangdong DFP New Material
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Syensqo
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Uniworth
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Goldstone Packaging
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Medicine Blister market?
The global Medicine Blister market is estimated at US$ 6.94 billion in 2025 (base year) and is projected to reach US$ 10.31 billion by 2032.
How fast is the Medicine Blister market expected to grow?
The market is expected to grow at a CAGR of 5.9% from 2026 to 2032, expanding from US$ 6.94 billion in 2025 to US$ 10.31 billion in 2032, roughly 1.5 times its base-year value.
What does the Medicine Blister market cover?
Blister film for drug packaging is a packaging method that seals the product between a blister formed by a transparent plastic sheet and a base plate (usually made of aluminum foil or plastic film, etc.). The blister packaging of drugs is formed by vacuum blistering (blowing) or compression molding, and after the blister is filled with drugs, a covering material such as aluminum foil is used to heat-seal it with the blister base material under certain temperature and time conditions by pressure.
How is the Medicine Blister market segmented by type?
By type, the market is segmented into PVC, PVDC, Aluminum Foil, Aclar and Others.
What are the key applications of Medicine Blister?
Key applications covered include Tablets Drug, Capsule Drug and Other.
Which companies are profiled in the Medicine Blister market report?
Key players profiled include Amcor, Constantia Flexibles, Klöckner Pentaplast, Liveo Research GmbH, WestRock, Tekni-plex, Honeywell and CPH GROUP, among 17 companies covered in total.
What geographies does the Medicine Blister market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Medicine Blister?
The global medicine blister packaging market is primarily driven by the increasing demand for unit-dose packaging in pharmaceuticals, which enhances drug safety, extends shelf life, and improves patient compliance.
What are the main risks and barriers in the Medicine Blister market?
Blister packs offer excellent barrier protection against moisture, light, and contamination, making them ideal for solid oral dosage forms such as tablets and capsules.
Who should buy the Medicine Blister market report?
The report is intended for manufacturers and solution providers, distributors and end users in Tablets Drug, Capsule Drug and Other, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Medicine Blister market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.